Experts to Discuss Bone Health after Breast Cancer

September 15, 2004

Breast cancer experts will discuss the risks to bone health following breast cancer, its causes and treatment options, during a special program at 5:30 p.m., Thursday, September 30. 

The program will cover the causes of bone density loss, the frequency of bone health problems after breast cancer treatment, and treatment options.  It is appropriate for pre- and postmenopausal women, women who have had chemotherapy, and women who are treated with the drugs tamoxifen, letrozole (Femara), and Anastrazole (Arimidex). 

Peggy Waterman, RN, a nurse practitioner with the James P. Wilmot Cancer Center at the University of Rochester Medical Center, will speak and Dr. Jennifer Griggs, medical director of the Comprehensive Breast Cancer Program at the Wilmot Cancer Center, will moderate the program. 

The Comprehensive Breast Cancer Program at the James P. Wilmot Cancer Center is sponsoring the dinner program, to be held at the University of Rochester Medical Center Conference Center’s William and Mildred Levine Pavilion, located at the corner of Elmwood Avenue and Kendrick Road.

The cost is $20 per person, which includes dinner.  Scholarships are available.  To register, call Kristin Galvin-Burwick at (585) 275-4797 or e-mail kristin_galvinburwick@urmc.rochester.edu.

Questions about the Comprehensive Breast Cancer Program may be directed to Griggs or Beverly Brooks, associate director of community education, at (585) 275-4797.

For Media Inquiries:
Leslie White
(585) 273-1119
Email Leslie White